SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000919574-23-001470
Filing Date
2023-02-14
Accepted
2023-02-14 12:15:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 d9940361_13g-a.htm SC 13G/A 122905
  Complete submission text file 0000919574-23-001470.txt   124422
Mailing Address 731 ALEXANDER ROAD BUILDING 2, SUITE 500 PRINCETON NJ 08540
Business Address 731 ALEXANDER ROAD BUILDING 2, SUITE 500 PRINCETON NJ 08540 609-419-1800
CAXTON CORP (Filed by) CIK: 0001388551 (see all company filings)

IRS No.: 222437619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601
Business Address 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601 844-445-5704
Xeris Biopharma Holdings, Inc. (Subject) CIK: 0001867096 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93215 | Film No.: 23625371
SIC: 2834 Pharmaceutical Preparations